Aroa Biosurgery reports low infection rates in 411-patient Myriad soft tissue reconstruction study
Reuters2026/09/07 00:47- Aroa Biosurgery announced peer-reviewed interim results from its ongoing MASTRR Registry evaluating Myriad in complex soft-tissue reconstruction.
- Results were published in Advances in Therapy, marking the latest disclosure from the registry rather than a future conference presentation.
- The analysis reported a favorable safety profile, with low infection rates in a high-risk, real-world inpatient population.
- No adverse events were deemed definitely related to Myriad products, supporting the device’s clinical positioning versus competing bioscaffolds.
- The company cited strong commercial momentum, including 54% sales growth in FY26, as the evidence base expands.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oranjebtc cancels 25 million treasury shares without capital reduction
The Last Time Treasury Yields Hit 6%, Bitcoin Didn't Exist — What Happens If They Get There Again?
Goldman Sachs: AI storage chip demand is underestimated, South Korean stock market still has 80% upside potential
Goldman Sachs Asia-Pacific Chief Equity Strategist Timothy Moe maintains a KOSPI target of 12,000 points, implying an almost 80% increase from the current level. He points out that the market is systematically underestimating the sustainability of the AI storage chip profit cycle. Capital expenditures by US tech giants may exceed $1.2 trillion next year, and the chip shortage triggered by data center expansion will further intensify in 2027. The current KOSPI is trading at only 5.3 times expected earnings, about half of its historical average.
Norwegian sovereign wealth fund may cut $80 billion US Treasury holdings; high-rated mortgage securities expected to become new favorites
Norway's sovereign wealth fund, with a scale of $2.3 trillions, has recommended reducing government bond holdings and reallocating funds towards higher-yielding fixed income assets.
